智美體育(01661.HK):擬收購香港兩家持牌法團控股公司的非主要控股權益
格隆匯3月25日丨智美體育(01661.HK)宣佈,於2020年3月25日,公司與賣方訂立一項無法律約束力的諒解備忘錄。根據諒解備忘錄,在後續具有法律約束力的買賣協議中將訂明的條款及條件規限下,公司將收購而賣方將出售一間於英屬處女羣島註冊成立的公司("目標公司")的非主要控股權益,該公司為獲證券及期貨事務監察委員會許可在若干條件規限下根據證券及期貨條例(香港法例第571章)可於香港進行受規管活動的兩家持牌法團的控股公司。可能收購事項的代價將於本公司對目標公司進行估值後釐定,並可進行調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.